연구 보고서
바이오의약품_기술120권.pdf
개요
1. 유전자치료제 기술개요
유전자치료제의 적용범위는 넓고 치료법의 한계에 도달한 암 및 심혈관질환 등의 난치성 질환 분야에 가능성이 높은 치료법으로 대두되고 있으며, 유전자치료제 산업은 이러한 각종 난치성 질병을 근원적으로 치료하는 신산업으로서 유전자 지도가 완성되고 각종 유전자의 기능이 밝혀지면서 더욱 활성화 될 것으로 예상하고 있음
가. 유전자치료제란?
1) 유전자치료제의 정의 및 특징
□ "유전자 치료"란 고전적인 의미에서 유전자 이상에 기인하는 질병을 치료하기 위하여 정상유전자를 환자의 체내에 도입하여 치료하는 기술을 말하며, 보다 광범위하게 다음과 같이 정의될 수 있음
○ "유전자 치료"란 세포에 유전자를 도입하여 질병을 치료하거나 예방하는 방법을 의미하며, 암 심혈관질환, 선천성 유전병 등의 소위 난치성 질환으로 분류되는 대부분의 질환이 치료대상이 됨.......계속
★ 첨부파일 다운로드가 안되시는 이용자께서는 아래 링크를 클릭하세요~!
목차
1. 유전자치료제 기술개요
가. 유전자치료제란? ··························································································· 1
1) 유전자치료제의 정의 및 특징 ·································································· 1
2) 유전자치료제 연구의 연구영역 및 기술분류 ·········································· 2
나. 유전자치료제에 거는 기대와 가능성 ························································· 3
2. 서지분석
가. 특허분석 ········································································································· 8
1) 해외특허로 살펴본 유전자치료제 분야 세계동향 ·································· 9
2) 해외에 출원된 특허로 살펴본 유전자치료제 분야 국내동향 ············· 15
3) 한국 특허청에 출원된 특허로 살펴본 유전자치료제 분야 국내동향 ·· 17
나. 논문분석 ······································································································ 21
1) 논문으로 살펴본 유전자치료제 분야 세계동향 ···································· 21
2) 논문으로 살펴본 분야별 유전자치료제 세계동향 ································ 25
3) 논문으로 살펴본 유전자치료제 분야 국내동향 ···································· 28
4) 논문으로 살펴본 분야별 유전자치료제 국내동향 ································ 31
다. 관련 시장 및 산업동향 분석 ···································································· 33
1) 유전자치료제 세계시장 분석 ·································································· 33
2) 해외 산업동향 ··························································································· 34
3) 국내 산업동향 ··························································································· 37
3. 기술개발동향
가. 세계동향 ······································································································ 38
나. 국내동향 ······································································································ 46
다. 주요국 정책동향 ························································································· 47
라. 주요국의 최근 유전자치료제 관련성과 ··················································· 50
마. 국내동향 ······································································································ 51
1) 관련 정책 수립 및 제도 마련 ································································ 51
2) 유전자치료제 R&D 현황 ········································································· 54
3) 국내 주요 연구자 및 연구성과 ······························································ 56
4. 시사점 및 대응방향
5. 참고문헌
지식
동향